# Safety of "Ticagrelor+ Warfarin"in Comparison With "Clopidogrel+Aspirin+Warfarin"

> **NCT02206815** · PHASE4 · COMPLETED · sponsor: **Genshan Ma** · enrollment: 296 (actual)

## Conditions studied

- Atrial Fibrillation
- Coronary Artery Disease

## Interventions

- **DRUG:** Ticagrelor+Warfarin
- **DRUG:** Clopidogrel+Aspirin+Warfarin

## Key facts

- **NCT ID:** NCT02206815
- **Lead sponsor:** Genshan Ma
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-09-19
- **Primary completion:** 2019-02-20
- **Final completion:** 2019-02-20
- **Target enrollment:** 296 (ACTUAL)
- **Last updated:** 2023-04-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02206815

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02206815, "Safety of "Ticagrelor+ Warfarin"in Comparison With "Clopidogrel+Aspirin+Warfarin"". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02206815. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*